Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis
Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis have?
Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis has 91 citations in the OpenAlex counts ScholarIQ stores.
When was Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis published?
Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis has 2019 year in the ScholarIQ index.
What is the open-access status of Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis?
Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis has gold oa status in the ScholarIQ index.
What is the DOI of Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis?
The DOI for Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis is on the source record.
What is the PMID of Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis?
The PMID for Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis is on the source record.
What is the OpenAlex record for Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis?
The OpenAlex for Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis is on the source record.